SOURCES:

Jackie Dishner, Phoenix.

Ziyad Al-Aly, MD, director, Clinical Epidemiology Center, Washington University, St. Louis; chief of Research and Development Service, Veterans Affairs St. Louis Health Care System.

Nature Medicine: “Acute and postacute sequelae related to SARS-CoV-2 reinfection.”

The Lancet eClinical Medicine: “Impact of COVID-19 vaccination on the chance of growing long-COVID and on current long-COVID signs: A scientific evaluate.”

The British Medical Journal: “Trajectory of lengthy covid signs after covid-19 vaccination: group based mostly cohort examine.”

Stephen J. Thomas, MD, director, Institute for Global Health and Translational Science, Upstate Medical University, Syracuse, NY.

Cell Death & Differentiation, “Long Covid: the place we stand and challenges forward.”

Scott Roberts, MD, affiliate medical director, an infection prevention, Yale New Haven Hospital, New Haven, CT.

Yale School of Medicine Iwasaki Lab: “Immunology of lengthy COVID.”

FDA: “Covid-19 Bivalent Vaccine Boosters.”

CDC: “Stay Up to Date with COVID-19 Vaccines Including Boosters,” “COVID Data Tracker, COVID in Your Community,” “COVID Data Tracker, COVID-19 Vaccinations within the United States.”

The New England Journal of Medicine: “A Bivalent Omicron-Containing Booster Vaccine in opposition to Covid-19.”

bioRxiv: “Improved Neutralization of Omicron BA.4/5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent BA.4/5 Vaccine.”

 

. .